Related Experiment Video
Updated: Jul 7, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner
M Caspi1, A Zilberberg, H Eldar-Finkelman
1Department of Anatomy and Anthropology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Abstract:
Beta-catenin is the central signalling molecule of the canonical Wnt pathway, where it activates target genes in a complex with lymphoid enhancer factor/T-cell factor transcription factors in the nucleus. The regulation of beta-catenin activity is thought to occur via a cytoplasmatic multiprotein complex that includes the serine/threonine kinase glycogen synthase kinase-3beta (GSK-3beta) that phosphorylates beta-catenin, marking it for degradation by the proteasome. Here, we provide evidence showing that GSK-3beta has a nuclear function in downregulating the activity of beta-catenin. Using colorectal cell lines that express a mutant form of beta-catenin, which cannot be phosphorylated by GSK-3beta and ectopically expressed mutant beta-catenin protein, we show that nuclear GSK-3beta functions in a mechanism that does not involve beta-catenin phosphorylation to reduce the levels of Wnt signalling. We show that GSK-3beta enters the nucleus, forms a complex with beta-catenin and lowers the levels of beta-catenin/TCF-dependent transcription in a mechanism that involves GSK-3beta-Axin binding.
Insights
Glycogen synthase kinase-3beta (GSK-3beta) has a novel nuclear role in Wnt signaling. Nuclear GSK-3beta reduces beta-catenin activity independently of phosphorylation, impacting gene transcription.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Beta-catenin is central to the canonical Wnt pathway, activating target genes with transcription factors.
- GSK-3beta typically phosphorylates beta-catenin in the cytoplasm, targeting it for proteasomal degradation.
- The precise mechanisms regulating beta-catenin activity, particularly in the nucleus, are not fully understood.
Purpose of the Study:
- To investigate the nuclear function of GSK-3beta in regulating beta-catenin activity.
- To elucidate the mechanism by which nuclear GSK-3beta downregulates Wnt signaling.
Main Methods:
- Utilized colorectal cell lines expressing a GSK-3beta-resistant mutant beta-catenin.
- Investigated the effects of ectopically expressed mutant beta-catenin protein.
- Examined the interaction between nuclear GSK-3beta and beta-catenin.
Main Results:
- Demonstrated that GSK-3beta enters the nucleus and directly interacts with beta-catenin.
- Showed that nuclear GSK-3beta reduces beta-catenin/TCF-dependent transcription independently of beta-catenin phosphorylation.
- Identified a mechanism involving GSK-3beta-Axin binding in this nuclear function.
Conclusions:
- GSK-3beta possesses a non-canonical nuclear function in downregulating Wnt signaling.
- This nuclear activity of GSK-3beta provides a new regulatory layer for Wnt pathway control.
- Findings suggest potential therapeutic strategies targeting nuclear GSK-3beta in Wnt-driven diseases.
More Related Videos
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
TGF - β Signaling Pathway
